60
Participants
Start Date
April 29, 2024
Primary Completion Date
May 31, 2026
Study Completion Date
July 31, 2026
Ketamine
Two ketamine hydrochloride (Ketamin Inresa 2 ml) infusions (interval 2-3 days) per week for three weeks, 6 infusions in total. Ketamine hydrochloride (Ketamin Inresa 2 ml) is applied continuously over a time span of 40 minutes with a subanesthetic dosage of 0.5 mg per kg body weight.
Placebo
Two times placebo (Isotone E NaCL 0.9 %) infusions (interval 2-3 days) per week for three weeks, 6 infusions in total. Placebo is applied continuously over a time span of 40 minutes.
CBASP
In addition to standard ward psychotherapeutic program (group and single sessions) with cognitive behavioural, sociotherapeutic, occupational therapy and physiotherapeutic elements, patients in the CBASP conditions receive one CBASP group session (50 min) per week for 12 weeks. The single sessions (one 50 min and one 25 min per week) contents are CBASP-specific.
TAU
Standard ward psychotherapeutic program (group and single sessions) with cognitive behavioural, sociotherapeutic, occupational therapy and physiotherapeutic elements.
RECRUITING
Universitätsklinikum Tübingen - Klinik für Psychiatrie und Psychotherapie, Tübingen
RECRUITING
Universitätsklinikum Jena - Klinik für Psychiatrie und Psychotherapie, Jena
German Center for Mental Health
UNKNOWN
University Hospital Tuebingen
OTHER